3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Breast
1
Conditions
Breast Neoplasms
6
Neoplasms
2
Multiple Endocrine Neoplasia Type 1
2
Neoplasms by Site
1
Neoplasm Metastasis
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Breast Diseases
1
Interventions
trastuzumab deruxtecan
1
taxane
1
ribociclib
1
pertuzumab
1
Trastuzumab
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Breast Diseases
×
Fulvestrant
×
Clear all
NCT02422615
2023-11-30
MONALEESA-3
Novartis
Phase 3
Completed
726 enrolled
17 charts
1 FDA